Molidustat 25 mg Tablets

Molidustat is an HIF-PH inhibitor ingredient. This 25 mg tablet entry is distinct from Varenzin oral suspension; the pictured MUSREDO tablet brand has a human reference formulation, not an approved feline tablet label.

Ingredient-level background

HIF-PH inhibition affects signalling involved in the erythropoietin response and red-cell production. That mechanism helps explain why molidustat appears in anaemia research and medicine references. It does not make every tablet and suspension the same clinical product.

An outer box and a blister are different quantities

Bayer’s Japanese MUSREDO reference describes 100-tablet outer boxes arranged as ten 10-tablet blister strips. A smaller supply quantity should be identified separately. State whether your enquiry concerns a full outer box or a specified number of tablets.

Tablet strength is not suspension concentration

25 mg denotes tablet strength. The concentration of a liquid is expressed in mg/mL, with a separate bottle volume. Neither the unit nor the dosage form should be dropped when comparing a prescription.

Reference information and veterinary assessment

Human tablet information and Varenzin’s cat-suspension label have different clinical contexts. Veterinary consideration of a tablet requires its own prescribing assessment, rather than copying a suspension’s instructions or approval status.